Sulfasalazine, a therapeutic agent for ulcerative colitis, inhibits the growth of CD44v9+ cancer stem cells in ulcerative colitis-related cancer
Ryo Seishima, Koji Okabayashi, Osamu Nagano, Hirotoshi Hasegawa, Masashi Tsuruta, Masayuki Shimoda, Kaori Kameyama, Hideyuki Saya, Yuko Kitagawa
研究成果: Article › 査読
8
被引用数
(Scopus)